RS58575B1 - Aktivni metabolit 1-[(2-bromofenil) sulfonil]-5-metoksi-3-[(4-metil-1-piperazinil) metil]-1h-indol dimezilat monohidrata i dimezilat dihidrat so aktivnog metabolita - Google Patents
Aktivni metabolit 1-[(2-bromofenil) sulfonil]-5-metoksi-3-[(4-metil-1-piperazinil) metil]-1h-indol dimezilat monohidrata i dimezilat dihidrat so aktivnog metabolitaInfo
- Publication number
- RS58575B1 RS58575B1 RS20190286A RSP20190286A RS58575B1 RS 58575 B1 RS58575 B1 RS 58575B1 RS 20190286 A RS20190286 A RS 20190286A RS P20190286 A RSP20190286 A RS P20190286A RS 58575 B1 RS58575 B1 RS 58575B1
- Authority
- RS
- Serbia
- Prior art keywords
- methyl
- active metabolite
- dimesylate
- bromophenyl
- piperazinyl
- Prior art date
Links
- XKDCUJBWVGDNSH-UHFFFAOYSA-N 1-(2-bromophenyl)sulfonyl-5-methoxy-3-[(4-methylpiperazin-1-yl)methyl]indole;methanesulfonic acid;hydrate Chemical class O.CS(O)(=O)=O.CS(O)(=O)=O.C12=CC(OC)=CC=C2N(S(=O)(=O)C=2C(=CC=CC=2)Br)C=C1CN1CCN(C)CC1 XKDCUJBWVGDNSH-UHFFFAOYSA-N 0.000 title 1
- -1 dihydrate salt Chemical class 0.000 title 1
- 239000002207 metabolite Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/14—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN4011CH2014 | 2014-08-16 | ||
| EP14825443.6A EP3180001B1 (en) | 2014-08-16 | 2014-10-20 | Active metabolite of 1-[(2-bromophenyl) sulfonyl]-5-methoxy-3- [(4-methyl-1-piperazinyl) methyl]-1h-indole dimesylate monohydrate and dimesylate dihydrate salt of active metabolite |
| PCT/IN2014/000667 WO2016027276A1 (en) | 2014-08-16 | 2014-10-20 | Active metabolite of 1-[(2-bromophenyl) sulfonyl]-5-methoxy-3- [(4-methyl-1-piperazinyl) methyl]-1h-indole dimesylate monohydrate and dimesylate dihydrate salt of active metabolite |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS58575B1 true RS58575B1 (sr) | 2019-05-31 |
Family
ID=52345478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20190286A RS58575B1 (sr) | 2014-08-16 | 2014-10-20 | Aktivni metabolit 1-[(2-bromofenil) sulfonil]-5-metoksi-3-[(4-metil-1-piperazinil) metil]-1h-indol dimezilat monohidrata i dimezilat dihidrat so aktivnog metabolita |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US10010527B2 (sr) |
| EP (1) | EP3180001B1 (sr) |
| JP (1) | JP6629322B2 (sr) |
| KR (1) | KR101938408B1 (sr) |
| CN (1) | CN106794170A (sr) |
| AP (1) | AP2017009752A0 (sr) |
| AU (1) | AU2014404000B2 (sr) |
| BR (1) | BR112017002921B1 (sr) |
| CA (1) | CA2957497C (sr) |
| CY (1) | CY1121393T1 (sr) |
| DK (1) | DK3180001T3 (sr) |
| EA (1) | EA031319B1 (sr) |
| ES (1) | ES2715113T3 (sr) |
| HR (1) | HRP20190446T1 (sr) |
| HU (1) | HUE044011T2 (sr) |
| IL (1) | IL250411B (sr) |
| LT (1) | LT3180001T (sr) |
| MX (1) | MX2017002045A (sr) |
| NZ (1) | NZ728907A (sr) |
| PL (1) | PL3180001T3 (sr) |
| PT (1) | PT3180001T (sr) |
| RS (1) | RS58575B1 (sr) |
| SG (1) | SG11201701106RA (sr) |
| SI (1) | SI3180001T1 (sr) |
| TR (1) | TR201903344T4 (sr) |
| WO (1) | WO2016027276A1 (sr) |
| ZA (1) | ZA201700915B (sr) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA03003397A (es) * | 2000-10-20 | 2004-06-30 | Biovitrum Ab | N1-(bencensulfonil)indoles sustituidos en las posiciones 2-, 3-, 4-, o 5 y su uso en terapia. |
| WO2003068220A1 (en) * | 2002-02-12 | 2003-08-21 | Akzo Nobel N.V. | 1-arylsulfonyl-3-substituted indole and indoline derivatives useful in the treatment of central nervous system disorders |
| US7875605B2 (en) * | 2002-11-28 | 2011-01-25 | Suven Life Sciences Limited | N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them |
| US7781476B2 (en) | 2002-12-18 | 2010-08-24 | Suven Life Sciences Limited | Tetracyclic 3-substituted indoles having serotonin receptor affinity |
| MX2009008324A (es) * | 2007-02-16 | 2009-10-20 | Memory Pharm Corp | Compuestos 6´-sustituidos que tienen afinidad con el receptor de 5-hidroxitriptamina-6. |
| CA2703157C (en) * | 2007-10-26 | 2013-02-05 | Suven Life Sciences Limited | Amino arylsulfonamide compounds and their use as 5-ht6 ligands |
-
2014
- 2014-10-20 PL PL14825443T patent/PL3180001T3/pl unknown
- 2014-10-20 SI SI201431124T patent/SI3180001T1/sl unknown
- 2014-10-20 EP EP14825443.6A patent/EP3180001B1/en active Active
- 2014-10-20 MX MX2017002045A patent/MX2017002045A/es active IP Right Grant
- 2014-10-20 TR TR2019/03344T patent/TR201903344T4/tr unknown
- 2014-10-20 HU HUE14825443A patent/HUE044011T2/hu unknown
- 2014-10-20 RS RS20190286A patent/RS58575B1/sr unknown
- 2014-10-20 JP JP2017527993A patent/JP6629322B2/ja active Active
- 2014-10-20 PT PT14825443T patent/PT3180001T/pt unknown
- 2014-10-20 ES ES14825443T patent/ES2715113T3/es active Active
- 2014-10-20 CA CA2957497A patent/CA2957497C/en active Active
- 2014-10-20 BR BR112017002921-9A patent/BR112017002921B1/pt active IP Right Grant
- 2014-10-20 EA EA201790396A patent/EA031319B1/ru unknown
- 2014-10-20 US US15/504,014 patent/US10010527B2/en active Active
- 2014-10-20 KR KR1020177004616A patent/KR101938408B1/ko active IP Right Grant
- 2014-10-20 DK DK14825443.6T patent/DK3180001T3/en active
- 2014-10-20 SG SG11201701106RA patent/SG11201701106RA/en unknown
- 2014-10-20 WO PCT/IN2014/000667 patent/WO2016027276A1/en active Application Filing
- 2014-10-20 LT LTEP14825443.6T patent/LT3180001T/lt unknown
- 2014-10-20 NZ NZ728907A patent/NZ728907A/en unknown
- 2014-10-20 CN CN201480081234.1A patent/CN106794170A/zh active Pending
- 2014-10-20 AP AP2017009752A patent/AP2017009752A0/en unknown
- 2014-10-20 AU AU2014404000A patent/AU2014404000B2/en active Active
-
2017
- 2017-02-02 IL IL250411A patent/IL250411B/en active IP Right Grant
- 2017-02-06 ZA ZA2017/00915A patent/ZA201700915B/en unknown
-
2019
- 2019-03-06 HR HRP20190446TT patent/HRP20190446T1/hr unknown
- 2019-03-08 CY CY20191100280T patent/CY1121393T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201602245B (en) | Inhibitors of kras g12c | |
| IL304500A (en) | A platform for the discovery and analysis of therapeutic substances | |
| IL245449A0 (en) | Tissue skeletal materials for tissue regeneration and methods of preparation | |
| EP2946523A4 (en) | METHODS AND NODES FOR DETECTING ACTIVATION OF A DESERT CELL | |
| HK1226396B (zh) | 用於大規模生產1-[(2-溴苯基)磺醯基]-5-甲氧基-3-[(4-甲基-1-呱嗪基)甲基]-1h-吲哚二甲磺酸鹽一水合物的方法 | |
| DK3255046T3 (da) | Hydroxyethylsulfonat af cyclin-afhængig proteinkinasehæmmer, krystallinsk form deraf og fremgangsmåde til fremstilling deraf | |
| EP3100489A4 (en) | MANUFACTURE OF AN INTERFACE BETWEEN THE ACCESS NECTS OF DIFFERENT RADIO ACCESS TECHNOLOGIES | |
| EP2961403A4 (en) | HETEROCYCLIC INHIBITORS OF SODIUM CHANNEL | |
| HRP20180773T1 (hr) | Otopine sildenafila, te postupci njihove priprave i upotrebe | |
| IL241711B (en) | A method for preparing sodium carbonate and/or sodium bicarbonate | |
| HRP20190446T1 (hr) | Aktivni metabolit 1-[(2-bromofenil) sulfonil]-5-metoksi-3-[(4-metil-1-piperazinil)metil]-1h-indol dimezilat monohidrata i dimezilat dihidrat sol aktivnog metabolita | |
| DK3394051T3 (da) | Krystallisationsprocedure til opnåelse af krystaller af canagliflozinhemihydrat | |
| GB2550742B (en) | Determination of density | |
| FR3039139B3 (fr) | Emballage-blister pour pile-bouton | |
| TH1501007118B (th) | หัวเอ็กซ์ทรูดชั่นพาริสัน สำหรับการทำโฟมแบบไม่ต่อเนื่อง (Extrusion Parison Head for Discontinuous Foaming) | |
| TH183427B (th) | โฟมชนิดเซลล์เปิดแบบชอบน้ำ | |
| TH1601003167A (th) | กระบวนการสำหรับการผลิตขนาดใหญ่ของ 1-[(2-โบรโมเฟนิล)ซัลโฟนิล]-5-เมทอกซี-3-[(4-เมทิล-1-พิเพอราซินิล)เมทิล]-1h-อินโดลไดเมซิเลตโมโนไฮเดรต | |
| TH1501007423A (th) | วิธีผลิตเซลล์ตั้งต้นของไตและเวชภัณฑ์ที่ประกอบด้วยเซลล์ตั้งต้นของไต |